President and founder of AYPharma Safety Consulting, with a vision of adding value through knowledge of drug safety and a mission to provide services that enhances the process of drug approval with a focus on all aspects of safety. Support multiple pharmaceutical clients safety needs.
Mentored colleagues in Pharmacovigilance and in running marathons.
An invited speaker and a moderator on numerous topics on non-clinical, clinical and business aspects of drug safety. Topics expanded from "value of animal models for pediatric clinical trials, Pharmacovigilance expertise in the process of drug-in licensing, ethics in the conduct of medical research, impact of genetic features on the outcome of cardiac arrythmia".